Malaria Mortality: Daily Death Toll, Epidemiology, and Prevention

Malaria remains a leading infectious killer. WHO 2023 estimates (2022 data):

• Cases: 249 million (85 countries).
• Deaths: 608,000 — ~1,665 deaths/day (not 2,000).
• Burden: Africa 94% cases, 95% deaths; children <5 = 78% of deaths.
• Parasites: P. falciparum (deadliest, Africa), P. vivax (Asia, Americas), P. malariae, P. ovale, P. knowlesi (zoonotic).

Transmission

Female Anopheles mosquito bite → sporozoites → liver stage (asymptomatic) → blood stage (cyclic fever, hemolysis, cytoadherence → severe malaria).

Prevention (Integrated Vector Management)

• Insecticide-treated nets (ITNs/LLINs): Core intervention; pyrethroid resistance rising.
• Indoor residual spraying (IRS): Where vectors endophilic.
• Chemoprevention: SMC (seasonal malaria chemoprevention) for children <5 in Sahel; IPTp (pregnancy); IPTi (infants).
• Vaccines: RTS,S/AS01 (Mosquirix) — WHO recommended 2021; R21/Matrix-M — 2023. Moderate efficacy (~30–75% severe malaria reduction).
• Larval source management, housing improvement.

Treatment

• ACTs (artemisinin-based combination therapies): First-line (artemether-lumefantrine, artesunate-amodiaquine, etc.).
• Severe malaria: IV artesunate (quinine if unavailable).
• Resistance: Artemisinin partial resistance (kelch13 mutations) in SE Asia, emerging in Africa; partner drug resistance.

Elimination Goal

WHO Global Technical Strategy 2030: reduce incidence/mortality 90%, eliminate in 35 countries, prevent re-establishment. Requires sustained funding, innovation, health system integration.